Improving family engagement in critical care settings
Increasing Family Engagement in Critical Care: The NGAGE Trial (The NGAGE Trial)
This study is testing a new tool to see if it helps families of ICU patients feel more involved and satisfied with their loved one's care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 194 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Lady Davis Institute Academic / other |
| Locations | 2 sites (Montreal, Quebec and 1 other locations) |
| Trial ID | NCT06586528 on ClinicalTrials.gov |
What this trial studies
This trial evaluates the effectiveness of the NGAGE tool in enhancing family engagement among relatives of ICU patients. It is a stepped wedge cluster randomized trial conducted across six adult ICUs in Canada, involving 194 family members. The NGAGE tool includes modules for learning, engaging, and reporting, allowing family members to communicate their desired involvement in patient care to the healthcare team. The study aims to improve communication, care satisfaction, psychological well-being, and quality of life for family members during the critical care experience.
Who should consider this trial
Good fit: Ideal candidates are adult family members of ICU patients who are expected to stay in the ICU for at least 48 hours.
Not a fit: Patients who do not wish to involve their family members in their care or those with repeat admissions during the study period may not benefit.
Why it matters
Potential benefit: If successful, this could significantly enhance the involvement and satisfaction of family members in the care of ICU patients.
How similar studies have performed: Other studies have shown positive outcomes with family engagement tools in critical care settings, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult family members (age ≥ 18 years) of ICU patients * Expected ICU stay ≥ 48 hours * Able to participate in English or French Exclusion Criteria: * Family members who do not wish to participate in care * Repeat admissions within the study period * Another family member has already participated in the study
Where this trial is running
Montreal, Quebec and 1 other locations
- Jewish General Hospital — Montreal, Quebec, Canada (Recruiting)
- McGill University Health Centre — Montreal, Quebec, Canada (Recruiting)
Study contacts
- Principal investigator: Michael J Goldfarb, MD, MSc — Lady Davis Institute, McGill University, Jewish General Hospital
- Study coordinator: Jillian Kifell, MSc
- Email: jillian.kifell.ccomtl@ssss.gouv.qc.ca
- Phone: 5143408222
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.